Otezla
Active substance: apremilast
KIT · apremilast
United StatesActive
Marketing holder: Amgen, Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 4 |
|
| EU 3 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-a681-7d1e-b441-d9dc5e5982f3,01a120c3-bcc7-71c0-9b5e-b9db31c87786,01a120c3-cf1f-7a15-a5bd-dc0ca1220e49,01a120c4-b7dc-75a6-8a9f-29054375b7f6;count=4 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-7838-7b26-9c4f-077b883d9c15,01a1208d-454d-74cb-9672-a0d7a0500f9c,01a1208e-7a20-76bd-9b43-a407672b5303,01a1208e-7a35-702b-8d4d-566e26808739,01a12096-4506-75d6-a71f-2be52d1521e5;count=8 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 55513-485
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 55513-485 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 55513-485 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 55513-485 · Verified 2026-10-09 · open in source